GA-BSA

Advanced glycation end products (AGEs) are formed from the nonenzymatic reaction of amino groups with reducing sugars. AGEs have been implicated in diseases, such as diabetes mellitus, non-diabetic nephropathy, macrovascular disease, Alzheimer's disease, cataract, and ageing. AGE receptors, such as the receptor for AGE (RAGE), mediate biological responses to AGEs, including endocytic uptake and degradation and induction of cytokines and growth factors. GA-BSA was produced by incubating BSA with glycolaldehyde, followed by extensive dialysis.Synonyms: AGE-BSA, Glycolaldehyde-Bovine Serum Albumin, Glycolaldehyde-BSA. Source: Albumin isolated from bovine plasma and modified with glycolaldehyde. MW: 69.3 kDa. Formulation: (Request formulation change), Lyophilized from a solution in PBS, pH 7.4, at 10 mg per vial. Reconstitution with 2 ml of 1X PBS will yield a 5 mg/ml solution.